Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy

Urology

Volumn 65, Issue 5, 2005, Pages 942-946

  Patel, Rupa ^d   Lepor, Herbert ^a,d   Thiel, Robert P ^c,d   Taneja, Samir S ^b,d  

^a MedReviews LLC   (United States)

^b Discovery Sciences   (United States)

^c ABBOTT LABORATORIES   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; ANALYTICAL PARAMETERS; BLOOD LEVEL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; FOLLOW UP; GLEASON SCORE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN VELOCITY; PROSTATECTOMY; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; SEMINAL VESICLE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 18844370372     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.12.013     Document Type: Article

References (26)

1. P. Carroll Rising PSA after a radical treatment Eur Urol 40 2001 9 16
2. W.J. Catalona, D.S. Smith 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer J Urol 152 1994 1837 1842
3. M. Han, A.W. Partin, C.R. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy the 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555 565
4. H. Zincke, J.E. Oesterling, M.L. Blute Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1994 1850 1857
5. J.A. Cadeddu, A.W. Partin, T.L. DeWeese Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy J Urol 159 1998 173 178
6. M.K. Garg, S. Tekyi-Mensah, S. Bolton Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy Urology 51 1998 998 1002
7. F.A. Vicini, E.L. Ziaja, L.L. Kestin Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer Urology 54 1999 111 117
8. D.M. Nudell, G.D. Grossfeld, V.K. Weinberg Radiotherapy after radical prostatectomy treatment outcomes and failure patterns Urology 54 1999 1049 1057
9. T.M. Pisansky, T.F. Kozelsky, R.P. Myers Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer J Urol 163 2000 845 850
10. A.K. Leventis, S.F. Shariat, M.W. Kattan Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy J Clin Oncol 19 2001 1030 1039
11. L.V. Do, T.M. Do, R. Smith Postoperative radiotherapy for carcinoma of the prostate impact on both local control and distant disease-free survival Am J Clin Oncol 25 2002 1 8
12. A.K. Chawla, H.K. Thakral, A.L. Zietman Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma analysis of efficacy and prognostic factors Urology 59 2002 726 731
13. D.Y. Song, T.L. Thompson, V. Ramakrishnan Salvage radiotherapy for rising or persistent PSA after radical prostatectomy Urology 60 2002 281 287
14. M. Peyromaure, M. Allouch, F. Eschwege Salvage radiotherapy for biochemical recurrence after radical prostatectomy a study of 62 patients Urology 62 2003 503 507
15. O.K. MacDonald, S.E. Schild, S.A. Vora Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy J Urol 170 2003 1833 1837
16. J.G. Trapasso, J.B. deKernion, R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
17. S.G. Roberts, M.L. Blute, E.J. Bergstralh PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer Mayo Clin Proc 76 2001 576 581
18. A. Patel, F. Dorey, J. Franklin Recurrence patterns after radical retropubic prostatectomy clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen J Urol 158 1997 1441 1445
19. C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
20. A.W. Partin, J.D. Pearson, P.K. Landis Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases Urology 43 1994 649 659
21. P. Kupelian, J. Katcher, H. Levin Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer Urology 48 1996 249 260
22. R.S. Pruthi, I. Johnstone, I.P. Tu Prostate-specific antigen doubling times in patients who have failed radical prostatectomy correlation with histologic characteristics of the primary cancer Urology 49 1997 737 742
23. M.O. Koch, R.S. Foster, B. Bell Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy J Urol 164 2000 749 753
24. C.R. Pound, A.W. Partin, J.I. Epstein Prostate-specific antigen after anatomic radical retropubic prostatectomy patterns of recurrence and cancer control Urol Clin North Am 24 1997 395 406
25. A.V. D'Amico, J.W. Moul, P.R. Carroll Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Natl Cancer Inst 95 2003 1376 1383
26. S.E. Schild, S.J. Buskirk, W.W. Wong The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy J Urol 156 1996 1725 1729